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51 In this study, the novel self-assembled carbazole-thiooctanoic acid nanoparticles (CTN) 
52 were synthesized from amino carbazole (a mutagen), and thiooctanoic acid (an antioxidant). 
53 The nanoparticles were characterized by hyperspectral techniques. Then, the 
54 antiproliferative potential of CTN was determined in HepG2 liver carcinoma cells. The 
55 study employed a solvent-antisolvent interaction method to synthesize a spherical CTN of 
56 size less than 50 nm. Moreover, carbazole-thiooctanoic acid (CT) was subsequently capped 
57 to gold nanoparticles (AuNPs) in the additional comparative studies. The CT derivative was 
58 synthesized from carbazole, and lipoic acid by amide bond formation reaction using 
59 coupling agent. Further, it was characterized by IR, 1H-NMR, DLS, and TEM techniques. 
60 The carbazole-thiooctanoic acid capped gold nanoparticles (CTAuNPs) was prepared from 
61 CT, chloroauric acid, and NaBH4. The CTAuNPs were characterized by UV–Vis, HRTEM, 
62 DLS, and FTIR techniques. The cytotoxicity and apoptosis-inducing ability of both 
63 nanoparticles were determined in HepG2 cells. The results demonstrate that CTN possess 
64 antiproliferative activity in the cancerous HepG2 cells. Moreover, molecular docking and 
65 molecular dynamics studies were conducted to explore the therapeutic potential of CT 
66 against human EGFR suppressor protein to gain more insights into the binding mode of the 
67 CT, which may show a significant role in anticancer therapy. 
68
69 Keywords: self-assembly; CTAuNPs; amino carbazole; lipoic acid; amphiphile; HepG2 
70 cells; apoptosis, EGFR
71
72
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74 Chemotherapeutic agents play a vital role in the treatment of cancer. Amongst them, 
75 carbazoles (a model DNA intercalator), and its derivatives have potential biological 
76 activities1. The enhanced cellular internalization of carbazole and its reduced toxicity to 
77 normal cells are significant in biological studies. In the recent past, nanodrug-based 
78 strategies are widely used to combat multidrug resistance (MDR)2. The enhanced 
79 permeability and retention (EPR) effect of self-assembled nanoparticles has garnered 
80 significant interest in drug delivery. A compound that combines two different drugs in one 
81 molecule has shown a synergistic effect in the treatment of diseases, and it can produce 
82 enhanced pharmacological effects. Such compounds are referred to as twin drugs and often 
83 show two different pharmacological activities in cancer cells3. Although several metals are 
84 used for nano synthesis, gold (inert metal) is preferred in medicine because of its low 
85 toxicity in healthy human cells. In general, antibodies and targeting moieties are conjugated 
86 by adsorption to the gold surface. A drawback of surface adsorption is the susceptibility of 
87 proteins to denaturation and in some cases limited ligand interactions with cell surface 
88 targets due to steric hindrance4. The capping of organic ligands such as amines, thiols5, 
89 dithiols, etc adds stability to gold nanoparticles. The interaction between ligand and the 
90 nanometal have been investigated earlier6. Dithiol ligands were conjugated to gold 
91 nanoparticles by sulfur ends7. The organic-capping layer formed duringmetal-ligand 
92 interactions plays a vital role in high-performance biomaterials8. Lipoic acid (LA) is a 
93 vitamin-like bioactive small molecule called antioxidant. The antioxidant important 
94 therapeutic potential in conditions where oxidative stress (ROS) is involved. It is sulphur-
95 rich compound found in cruciterous vegetables like broccoli and cabbage9. 
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98 Figure 1. The literature reported amphiphilic Drug–Drug conjugate for cancer therapy
99 Nano drugs self assembled delivery systems are the most important for cancer chemotherapy 
100 and it is considered a better method because of their stability in the bloodstream, high drug 
101 loading and controllable release from carriers at target sites10. Moreover, this strategy can 
102 improve the efficiency of cellular uptake because of their ability to enhance drug delivery 
103 efficacy and reduce drug side effects. Different amphiphilic drug-drug conjugate have been 
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104 made using dissimilar of hydrophobic and hydrophilic drugs (Fig. 1). The resulting 
105 amphiphilic twin drugs could self-assemble into nanoparticles with high drug loading and 
106 improve cancer therapeutic efficacy. For example, irinotecan as hydrophilic anticancer drug 
107 and chlorambucil hydrophobic anticancer drug were conjugated through the hydrolyzable 
108 ester linkage11. The amphiphilic nanoparticles were composed of two drug-drug conjugates, 
109 including doxorubicin (DOX)-chlorambucil (Cb) and irinotecan (Ir)-Cb conjugates. 
110 Floxuridine (FdU) as hydrophilic anticancer drug was tethered with hydrophobic anticancer 
111 drug of bendamustine (BdM) to form amphiphilic twin drug12. The twin drug molecules 
112 interconnected by an ester bond or amide bond could readily self-assemble into stable and 
113 uniform nanoparticles. The nanoparticles can be delivered to the action sites of a body via 
114 physical entrapment or chemical conjugation, better therapeutic efficacy against tumors and 
115 without side effects over free drugs. More importantly, after uptake by tumor cells and 
116 chemoenzymatic activity, the conjugates could be easily disintegrated into individual free 
117 drugs and it can induce nonoverlapping but synergistic pharmacological effects and 
118 simultaneously improve the therapeutic efficacy in vitro. Direct conjugation of hydrophobic 
119 drug and small organic compounds is recently established as a new nano-drug delivery 
120 system. Due to a wide variety of therapeutic applications, nitrogen-containing heterocycles 
121 hold its significancein medicine13, and carbazole derivatives are one such example. The 
122 thiooctanoic acid (lipoic acid) belongs to the family of tocopherols and tocotrienols. The 
123 mutagen-amino carbazole (AC) and antioxidant-lipoic acid (LA) are the unique compounds; 
124 they are expected to excel for cancer therapeutic applications and may be suitable candidates 
125 to solve the drawbacks. The present study chose the hydrophobic amino carbazole (AC) and 
126 hydrophilic lipoic acid (LA) for synergistic combination in chemotherapy. Moreover, 
127 carbazole thiooctanoic acid (CT) functionalized gold nanoparticles were synthesized. The 
128 newly synthesized carbazole self-assembled nanoparticles and conjugated gold 
129 nanoparticles were evaluated for their antiproliferative activities against HepG2 cells. The 
130 amphiphilic self-assembled nanoparticles (CTN) increased the activity of the extrinsic 
131 caspase 8, intrinsic caspase 9 and executioner caspases and LDH release was not altered 
132 significantly suggesting apoptosis instead of necrosis. Furthermore, the molecular docking 
133 and molecular dynamics of mono CT molecule to EGFR were performed, to explore the 
134 other possible target.
135
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136 2. Results and Discussion
137 The compound carbazole thiooctanoic acid (CT) [3] was synthesized by reacting 3-amino-
138 9-ethyl carbazole (AC) [1] and lipoic acid (LA) [2] in the presence of HBTU and DIEA. 
139 The base deprotonates the carboxylic acid. The resulting carboxylate anion attacks the 
140 electron-deficient carbon atom of HBTU (Fig. 2). The resulting HOBt anion reacts with the 
141 newly formed activated carboxylic acid derived intermediate to form an OBt activated ester. 


































































147 Figure 2 Synthesis of carbazole thiooctanoic acid (CT) [3] and Plausible ‘’amine to amide’’ 
148 mechanism for the formation of CT
Page 8 of 35
































































150 Lipoic acid is a water-soluble antioxidant and amino carbazole is a water-insoluble DNA 
151 intercalator. Therefore, the resultant CT molecule is amphiphilic and self-assembles to form 
152 nanoparticles in an aqueous environment, a  benefit derived from the amphiphilic nature 
153 (Fig. 3). The dialysis method was employed to prepare the self-assembled CT twin drug 
154 nanoparticles. The acetone solution of CT was added with deionized water and dialyzed to 





160 Figure 3 Schematic route for the formation of amphiphilic twin bioactive molecule and its 
161 self-assembly for endocytosis.
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164 Figure 4 Morphology of amphiphilic CT nanoparticles
165
166
167 Figure 5 DLS profile: size distribution of CT nanoparticles with PDI:0.041
168
169
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170 The characteristic amphiphilicity of the CT provides an chance for itself to self-assemble 
171 into organic nanoparticles in water. The TEM study determine the size and morphology of 
172 the self assembled nanoparticles (Scale bars: 200 nm and 50 nm) (Fig. 4). The TEM image 
173 shows that the CT nanoparticles aggregates into approximate spherical particles in aqueous 
174 solution, and the size determined by TEM is about 70 ± 8.0 nm, The DLS results in (Fig. 5) 
175 show that the CT nanoparticles solution forms aggregates and the mean hydrodynamic 
176 diameter of CT nanoparticles aggregates is about 371.5 nm with a narrow unimodal size 
177 distribution. This size is smaller than that measured by DLS due to the shrinkage of CT 
178 nanoparticles in a drying non-solvated state during TEM sample preparation. The solution 
179 of CT nanoparticles was stored at 4°C in refrigerator.  The value of PDI is always under 
180 0.041 at room temperature (Fig. 5) . The results demonstrate that CT nanoparticles are 
181 extremely stable during storage. 
182 The CTAuNPs was formed by the addition of an aqueous solution of CT to chloroauric acid 
183 solution. After stirring the solution at room temperature, NaBH4 was added dropwise. Fig. 
































187 Figure 6 The outline for the synthesis of CT capped gold nanoparticles (CTAuNPs)
188
189 The formation of gold nanoparticles was initially confirmed when the solution turned into 
190 ruby red color. In Fig. 7 the UV–vis spectra of CTAuNPs is shown. The characteristic peak 
191 at 530 nm (Fig. 7curve a) indicates the formation of gold nanoparticles which was due to 
192 thesurface plasmon excitation of gold nanoparticles26. A bathochromic shift with the 
Page 11 of 35































































193 appearance of a broad peak at 552 nm (Fig. 7 curve b) was observed due to the aggregation 
194 and surface modification of gold nanoparticles. When carbazole interacted with the gold 




199 Figure 7 UV-vis spectra of  gold nanoparticles line (A) (red color) and CT capped gold 
200 nanoparticles line (B) (blue color)
201
202 The UV-vis spectrum of the synthesized gold nanoparticle was determined. The size and 
203 shape of the nanoparticle were observed with TEM and supported by hydrodynamic size. 
204 Zeta potential measurements were observed using Dynamic Light Scattering (DLS) 
205 instrument. The observed nanoparticles were mono-dispersed and exactly spherical or 
206 nearly spherical with size ranging from 5-10 nm (Fig. 8). Also, spherical shaped gold 
207 nanoparticles were observed.
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209 Figure 8 HRTEM images of (A) gold nanoparticles, (B) gold nanoparticles capped with 
210 CT,  and (C) a part of spherical gold nanoparticle and its corresponding fast Fourier 
211 transformed image
212
213 Zeta potential is an indication of colloidal stability27.  Zeta potential of nanoparticles with 
214 +30 mV or  -30 mV is more stable. Colloids having a lower zeta potential results in 
215 aggregation due to Van Der Waals forces27. HRTEM and DLS adopt different principles for 
216 the measurement of particle size. Hence the particle size measured by HRTEM and DLS 
217 differs in the margin. Zeta potential was found to be -0.172 mV (Fig. 9B) which shows its 
218 least stability. The average hydrodynamic particle size by DLS showed 45 nm (Fig. 9A) 
219 which is identical to that observed by HRTEM.
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Figure 9 (A) Particle size distribution of CTAuNPs by DLS method (B) Zeta potential measurement 
by Zeta sizer
Page 14 of 35
































































228 Figure 10 The FTIR Profile of CT (line A) and CTAuNPs (line B)
229
230 Fig.10 shows the FTIR spectra which compares the spectra of CT and CTAuNPs. A 
231 stretching frequency at 3237 and 1587 cm-1 confirmed the NH and S-S functional groups of 
232 CTN. The NH band was observed for CTAuNPs, but it was shifted to higher values. Also, 
233 the sulfur bond presenting in CT was absent thereby containing an attachment of CT into 
234 the gold surface. The S-S group was present in the IR spectra as indicated in Fig 10A and B 
235 indicating that it did not participate in any linkage or interaction with the gold surface .
236 In vitro assays
237 The anticancerpotential of CTN and CTAuNPs was determined using a liver carcinoma 
238 derived (HepG2) cell line.  The antiproliferative activities were screened using the MTT 
239 assay.
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241 Figure 11 MTT evaluation of cell viability for CTN (A) and CTAuNPs (B) in HepG2 cells
242
243 The decrease in cell viability after exposure for 6 hours was dose-dependent with higher 
244 concentrations displaying the most significant loss to cell viability. IC50 values obtained for 
245 CTN and CTAuNPs were 91.3 µg/mL and 432 µg/mL respectively (Fig. 11). While gold-
246 capped nanoparticles easily penetrate cell membranes and are often described as an effective 
247 drug carrier, our data indicate that the self-assemble organic CTN displayed greater 
248 effectiveness in decreasing cell viability when compared to the gold derivative. Gold 
249 nanoparticles display diverse and unique properties that may contribute to cell protective 
250 mechanisms after acute treatments such as anti-oxidant defense mechanisms and altered the 
251 energy flux. Therefore, only CTN was selected for further biological assessment.
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253 Figure 12 Schematic representation of CTN induced apoptosis
254 The cytotoxic potential of carbazole derivatives has already been established in several in 
255 vitro models28. Our innovative conjugation of a carbazole to the antioxidant and 
256 mitochondrial stimulator i.e., α-lipoic acid has sown a profound effect on caspase initiation 
257 and activation (a marker for apoptosis). Apoptosis or programmed cell death regulates the 
258 elimination of damaged cells to maintain homeostasis. Caspases are critical facilitators of 
259 apoptosis as they initiate and execute the process via two pathways: the extrinsic and the 
260 intrinsic pathway. The extrinsic pathway is stimulated by ligands binding to receptors that 
261 regulate downstream adaptor molecules resulting in caspase 8 activation (Fig. 12). The 
262 intrinsic pathway involves the binding of caspase 9 to the apoptotic protease-activating 
263 factor-1 (APAF-1) apoptosome complex in response to mitochondrial signals such as 
264 membrane depolarization. Both pathways result in the activation of executioner caspases, 
265 caspase 3/7.  
266 Our data indicates the enhanced activity of executioner caspases 3/7 (Fig. 13C). The 
267 initiators of the extrinsic (Fig. 13A) and intrinsic (Fig. 13B) apoptotic pathways are also up-
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Figure 13 (A) CTN increased the activity of the extrinsic caspase 8,(B) intrinsic caspase 9 and (C) 
executioner caspases 3/7. Key: *** p<0.001 p<0.05
268 regulated. It is intriguing that caspase activity increases in a dose-dependent manner but 
269 drastically decreases at the highest CTN concentration. We speculate that this may be due 












282 Figure 14 Effect of CTN on ATP detection
283 The plasma membrane integrity was evaluated by determining LDH release into the 
284 supernatant. Plasma membrane leakage is strongly correlated with overt cytotoxicity and 
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Figure 15 Effect of CTN on LDH leakage
285 necrotic cell death. We observed no significant changes to the levels of released LDH (Fig. 
286 15) suggesting that apoptosis was responsible for cell death and not necrosis. The results are 
287 in agreement with the caspase activity assays. Triggering apoptosis without overt necrosis 
288 would be the preferred means of destroying cancer cells as it dampens many of the damaging 
289 side effects.  This is important to normal healthy cells that may not be affected by the drug 










300 In silico analysis to investigate the other anticancer target 
301
302 Molecular docking and molecular dynamics are the in-silico approaches to predict the ligand 
303 binding pose inside the target protein or host molecule29. The application of molecular 
304 docking to predict the therapeutic and metabolic profiles has been well documented30. In the 
305 present study, molecular docking and molecular dynamics have been employed to 
306 investigate the therapeutic anticancer potential of carbazole, lipoic acid, and carbazole-
307 thiooctanoic acid.  
308 Molecular docking has been used as a tool to evaluate the interaction and geometric 
309 conformation of a ligand-biological target31. The potential mechanism of carbazole is the 
310 inhibition of epidermal growth factor receptor (EGFR). EGFR is a validated target for the 
311 treatment of cancer28, 32. Therefore, carbazole, lipoic acid, and carbazole-thiooctanoic acid 
312 were docked into the binding site of EGFR to explore the anticancer therapeutic potential. 
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313 Carbazole, lipoic acid, and carbazole-thiooctanoic acid were respectively shown the docking 
314 scores of -7.2, -4.8, and -7.9 kcal/mol (Table 1). The range of root mean square deviation 
315 for each of the molecule [aminocarbazole (AC), lipoic acid (LA), and carbazole-
316 thiooctanoic acid (CT)] from the top-ten ranked pose is shown in Table 1. Carbazole-
317 thiooctanoic acid has shown the highest docking scores of (-7.9 kcal/mol) in comparison to 
318 carbazole and lipoic acid. Carbazole-thiooctanoic acid (CT) is the combined molecular 
319 fragments of carbazole and lipoic acid. The combined molecular feature may be responsible 
320 for the achievement of the highest molecular docking score. The interacting residues of 
321 EGFR and its interaction with mono CT were shown in Fig 16 and Fig 17. Val21, Leu22, 
322 Ala47, Thr92, Asp157, and Arg143 were found to be binding site residues for carbazole-
323 thiooctanoic acid at the binding site of EGFR in molecular docking.
324 Table 1. Molecular docking scores of the molecules (Aminocarbazole, Lipoic acid, and 
325 CT)
No. Molecule Docking scores RMSD (lb) RMSD (ub)
1. Aminocarbazole -7.2 0.00 – 1.598 0.0 – 4.567
2. Lipoic acid -4.8 0.00 – 4.479 0.0 – 5.888
3. CT -7.9 0.0 – 3.202 0.0 - 6.032
326
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328 Figure 16. The interaction pattern of CT with EGFR in molecular docking
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330 Figure 17. The binding landscape of CT inside the ligand binding site of EGFR in 
331 molecular docking
332 The highest docking score of -7.9 kcal/mol has been obtained for the complex of carbazole-
333 thiooctanoic acid with EGFR in molecular docking. Therefore, the complex has been 
334 subjected to molecular dynamics simulation. The results of molecular dynamics simulation 
335 help to ensure the binding affinity of the ligand and stability of the complex from the 
336 estimated of energy components. Molecular dynamics simulation was carried out for the 
337 complex of carbazole-thiooctanoic acid with EGFR in AMBER 1833. Initially, the molecular 
338 docking complex was pre-treated in Chimera before submitting to molecular dynamics34. 
339 The ligand-bound complex was used as an initial geometry for molecular dynamics. The 
340 ligand and the protein were parametrized in Antechamber and tleap35. The complex was 
341 neutralized by adding (Na+/Cl-) as counter ions and the complex was solvated using TIP3P 
342 water model36. The minimization of the complex was carried out for 200 steps. The heating 
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343 and equilibrium were conducted at 300K. Then, the simulation of the complex system was 
344 carried out for 5 ns37. The results of the trajectories were saved for every 1ps and were 
345 analyzed using CPPTRAJ module38. After the 5 ns simulation, the binding free energy of 
346 the ligand-protein complex (carbazole-thiooctanoic acid with EGFR) was estimated by the 
347 Molecular Mechanics/Poisson Boltzmann Surface Area (MM/PBSA) method. The 
348 estimated energy components were depicted in Table 2. The estimated VDWAALS 
349 components were found to be (-45.31 kcal/mol). The stability and flexibility of the complex 
350 were analyzed from the RMSD and RMSF plot (Fig 18). Moreover, the complex has shown 
351 a strong binding free energy of (-39.86 kcal/mol) from the binding free energy calculation 
352 (Table 2). This strong binding affinity of carbazole-thiooctanoic acid with EGFR shows its 
353 therapeutic potential as an anticancer agent.
354
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356 Figure 18. (A) RMSD and (B) RMSF plots of the carbazole-thiooctanoic acid (CT) with 
357 EGFR complex in molecular dynamics simulation
358
359 Table 2. The energy components of CT-EGFR complex in molecular dynamics simulation
Energy Component Average Std. Dev.
               
Std. Err. Of
Mean
VDWAALS -45.3100 3.8646 0.3865
EEL -15.7461 7.0271 0.7027
EGB 27.0712 4.9542 0.4954
ESURF -5.8744 0.3937 0.0394
DELTA G gas -61.0561 9.8450              0.9845
DELTA G solv 21.1968 4.6821 0.4682
DELTA TOTAL -39.8593 6.1557              0.6156
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361 6. Conclusion 
362
363 In this study, Utilizes self-assembly amphiphilic carbazole-thiooctanoic acid (CTN) 
364 nanoparticles i.e., aminocarbazole (mutagen) and lipoic acid (antioxidant) as two in one 
365 molecule to investigate the biochemical mechanism of the binary molecule on human 
366 cancerous liver (HepG2) cells. The carbazole-thiooctanoic acid capped gold nanoparticles 
367 (CTAuNPs) were synthesized, characterized, and apoptotic induction activity of the same 
368 was studied. To prove the interaction between disulfide and AuNPs, the spectroscopic 
369 analysis was performed. It showed the disulfide group of carbazole lipoic acid acting as a 
370 potential site to conjugate with the gold surface at nanoscale, resulting in carbazole capped 
371 gold nanoparticles. The CTN increased the activity of the extrinsic caspase 8, intrinsic 
372 caspase 9 and executioner caspases and LDH release was not altered significantly 
373 suggesting apoptosis instead of necrosis in liver carcinoma (HepG2) cells. The results 
374 indicated that self-assembled carbazole nanoparticles CTN induces apoptosis in the absence 
375 of overt necrosis in liver carcinoma (HepG2) cells and it may be a novel anti-cancer agent. 
376 Moreover, the in-silico studies like molecular docking and molecular dynamics have shown 
377 the strong binding affinity for carbazole-thiooctanoic acid (CT) with EGFR. In post-
378 dynamics, this complex has shown substantial stability during the simulation. Therefore, 
379 carbazole-thiooctanoic acid may act as potential anticancer agents. 
380
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381 2. Materials andMethods
382 2.1. Chemicals and reagents
383 Gold (III) chloride trihydrate (HAuCl4.3H2O), 9-ethyl-3-amino carbazole, 
384 Hexafluorophosphate Benzotriazole Tetramethyl Uronium (HBTU), 
385 Diisopropylethylamine (DIEA), lipoic acid, and NaBH4 were procured from Sigma Aldrich, 
386 South Africa. Other chemicals were procured as analytical grade and do not require 
387 purification. Reagents used for the study were prepared using distilled water. Glasswares 
388 were washed thoroughly using aqua regia followed by double distilled water.
389 2.2. Synthesis of novel carbazole thiooctanoic acid (CT)
390
391 15 ml of Dimethylformamide (DMF) and 5ml of Tetrahydrofuran (THF) was used to 
392 solubilize lipoic acid (0.55 g, 2.75 mmol) and then added with HBTU (1 g, 3.05 mmol), 
393 DIEA (1 ml, 6.00 mmol) and 9-ethyl-3-amino carbazole (0.56 g, 2.7 mmol). The resultant 
394 mixture was fully dissolvedusing magnetic stirrer at room temperature. TLC analysis was 
395 performed to check for conjugation. 50 ml of distilled water was added to the resultant 
396 mixture and then extracted with ethyl acetate (25 ml) for three times. Ethyl acetate layer was 
397 combined and then dried by passing it through anhydrous sodium sulfate followed by 
398 evaporation to yield the crude product.  Finaly, a white solid CT was obtained  after 
399 purification using column chromatography (50:50 EtOAc/Hexane). Yield: 1.10g (92%); 
400 mp: 120 °C; IR (KBr, cm-1): 3462.01, 3237.92, 3058.40, 2917.84, 2513.46, 2513.46, 
401 1900.406, 1773.85, 1736.05, 1650.38, 1587.43, 1542.65, 1485.11, 1382.07, 1277.01, 
402 1228.44, 1152.46, 1123.774, 1085.725, 1060.128, 1020.12, 1020.128, 978.56, 888.97, 
403 821.95; 1H-NMR (400 MHz, CDCl3): δ  (ppm) 1.35 (m, 2H), 1.39 (s, 3H), 1.56 (q, 2H), 1.68 
404 (m, 2H), 1.80 (m, 2H), 2.40 (t, 2H), 2.62 (m, 1H), 3.34 (m, 2H), 3.5 (t, 1H), 4.35(q, 2H), 
405 7.0-7.1 (s, 1H), 7.16-7.19 (t, H), 7.29 (s, 1H), 7.31.(s, 1H), 7.37-7.36 (d, 1H), 7.418-7.41 
406 (m, 1H), 8.20 (d, 1H), 8.42 (t, 1H); 13C-NMR (400 MHz, CDCl3,): δ (ppm) 171.00, 140.44, 
407 137.23, 129.61, 125.85, 123.02, 122.75, 120.66, 119.49, 118.73, 112.91, 108.53, 108.45, 
408 58.43, 40.28, 48.48, 37.39, 37.37, 34.69, 33.94, 28.93, 25.43, 24.94, 13.80. 
409 2.3. Formation of carbazole nanoparticles (CTN)
410 At room temperature, novel carbazole thio octanoic acid (CT) twin bioactive molecules (25 
411 mg) was dissolved in acetone (20 mL). All the prepared CT solutions were syringe filtered 
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412 (pore size 0.22 µm).  Subsequently, the antisolvent deionized water (20 ml) was added in 
413 drops to the solution and stirred gently for half an hour, and the nanoparticle was 
414 precipitated. This technique was termed as antisolvent precipitation technique. The 
415 appearance of turbidity indicated the formation of amphiphile CT Nanoparticles (CTN) 
416 from CT twin bioactive molecules. 
417 2.4. Characterization of carbazole nanoparticles (CTN)
418 Particle size (z-average diameter, d/nm), polydispersity index (PDI) Fig. 5, and zeta 
419 potential of the precipitated nanoparticles were analyzed using dynamic light scattering 
420 (DLS) (Zetasizer Nano ZS, Malvern Instrument Ltd., UK) at 25°C. Particle size and shape 
421 of the nanoparticle were characterized by transmission electron microscopy (TEM) Fig. 4. 
422 CTNNPs (1µl) were kept on formvar coated grids, air-dried, and observed at 100 kV for 
423 TEM (JEOL 1010 TEM using a Megaview III camera and iTEM software) studies.
424 2.5. Synthesis of novel carbazole thiooctanoic acid capped gold nanoparticles (CTAu 
425 NPs)
426 The sodium borohydride reduction method was adopted to synthesize gold nanoparticles14. 
427 Briefly, 0.01 g of NaBH4 was employed to reduce tetrachloroauric acid (10-4 M) leading to 
428 the synthesis of gold nanoparticles of  5nm in diameter. The resultant nanoparticle solution 
429 was ruby-red in colour. Subsequently, 10-3 M aqueous solution of CT was used as a capping 
430 agent for gold nanoparticles.Then the solution wasrepeatedly centrifuged (10,000 rpm for 
431 1hour) to purify the carbazole thiooctanoic acid capped gold nanoparticles.
432 The absorption spectra (200nm - 800nm)of the capped gold nanoparticles solution was 
433 measured using a UV-vis spectrometer (Varian Cary-50 UV spectrophotometer linked to a 
434 TCC-240A Shimadzu heating vessel temperature controlled cell holder).To analyze the size 
435 and shape, 1 µl of the CTAu NPs was kept on formvar coated grids, air-dried, and observed 
436 using TEM. For FTIR studies, CTAu NP was purified by centrifugation (10,000 rpm for 
437 10min) and the resultant pellet was washed thrice using distilled water (20 ml). Then the 
438 FTIR spectra were recorded using Varian 800 FTIR spectrophotometer.Particle size and 
439 zeta potential were evaluated using a Differential Light Scattering Malvern Zetasizer Nano 
440 ZS (Malvern Instruments Ltd, UK) Merck 2423 instrument.
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441 2.6. Cell culture
442 The HepG2 human liver carcinoma cells were grown in 25cm3 culture flasks (37°C, 5% 
443 CO2) in complete culture media (CCM, Eagles Minimum Essential media, supplemented 
444 with 10% fetal calf serum, 1% L-glutamine, and 1% penicillin-streptomycin-fungizone) 
445 until to obtain 90% confluent. Then, the cells were harvested by trypsinization and used for 
446 the relevant assays.
447 2.7. Cell viability 
448 MTT assay was adopted to analyze the cell viability. HepG2 cells (15,000 cells/well) were 
449 seeded in a 96 well microtitre plate and incubatedovernight to adhere to the plate. The cells 
450 were incubated for 6 hrs with varying concentrations of CTN and CTAu (0-750 µg/mL) in 
451 five replicates. The plate wasincubated at 37°C for 4 hours after the addition of 120 µl of 
452 MTT/CCM solution (5mg/mL) into each well.  Supernatants were decanted,  added with 
453 100µl of DMSO,and incubated for 1 hr (37°C). The absorbance was read using a 
454 spectrophotometer (Bio-Tek μQuant) at a wavelength of 570/690 nm. The percentage of 
455 viable cells was measured and a dose-response curve was generated from which the IC50 
456 value was extrapolated. 
457 For further analysis, the cells were exposed to sub and overt IC50 concentrations for a dose-
458 dependent study of the novel compound. All these experiments were performed thrice 
459 independently in triplicate. 
460 2.8. ATP assay
461 HepG2 cells (20,000cells) were seeded into each well of the 96 well-plate along with 20μl 
462 CellTire Glo™ reagent (Promega, Madison, USA) and incubated in dark for 30 mins at 
463 room temperature (RT). The luminescent signal was then read using a Modulus™ 
464 microplate luminometer (Turner Biosystems, Sunnyvale, USA). The strength of the signal 
465 corresponds to the concentration of intracellular ATP. Results werementioned in mean 
466 relative light units (RLU). All these experiments were repeated thrice in triplicate.
467 2.9. Caspase assay
468 The Caspase Glo® 8, 9 and 3/7 Assay kits (Promega, Madison, USA) were used to detect 
469 caspase activity. The same procedure was followed for the listed caspases: treated and 
470 untreated cells (20,000 cells) were seeded into each well of the 96 well-plate along with20μl 
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471 of Caspase Glo® reagent(prepared as per the instruction manual) and incubated in dark for 
472 30 mins at RT. Theluminescence was detected and quantified using a Modulus™ microplate 
473 luminometer (Turner Biosystems, Sunnyvale, USA). The data wererepresented as mean 
474 relative light units (RLU).
475 2.10. LDH assay
476 The LDH cytotoxicity detection kit (Roche, Mannheim, Germany) was employed to 
477 determine cell death that occurred through membrane damage. Briefly, the supernatant 
478 (100μl) of control and treated cells were added to the wells of 96-well microtitre plate 
479 followed by substrate mixture and left for 25 mins at RT, for the reaction to occur. Here 
480 substrate mixture has a catalyst (diaphorase/NAD+) and dye (INT/sodium lactate). Optical 
481 density was recorded spectrophotometrically at 500nm (Bio-Tek uQuant). The results are 
482 expressed in mean ± standard deviation (SD) of optical density. All these experiments were 
483 repeated thrice in triplicate.
484 3. Molecular docking 
485 Molecular docking is used as a tool to view the interaction/selectivity of a ligandto the active 
486 site pocket of protein15. The 3D structure of EGFR (PDB code:6JXT) was acquired from 
487 the Protein Data Bank16. Thestructure of carbazole, lipoic acid, and CT was built using 
488 ChemDraw software. To optimize the geometry of ligand, MM2 force field was 
489 employed17. The docking was carried out to study the interactions and the binding affinity 
490 of barbazole, lipoic acid, and CTwith EGFR. A grid box with the spacing of 1 Å and size of 
491 15 × 15 × 15 pointing in x, y, and z directions was defined at the proximity of bound ligand 
492 in EGFR using the standard protocoll8,19. Then the molecules were docked using 
493 AutoDockVina17 with standard docking parameters. The Lamarckian Genetic Algorithm 
494 was used as the search algorithm with standard parameter values. The ideal docked 
495 conformation was chosen for further investigations. Details of docking parameters are 
496 described in our previous communications21,22 PyMol23, Discovery Studio Visualizer24, and 
497 LigPlot+ 25 were employed to visualize and analyse the structure of the docked complex.
498 4. Statistical analysis
499 Biological experiments were conducted thrice (independently) in triplicate. Statistical data 
500 was evaluatedby one way ANOVA and the Bonferroni test for multiple group comparisons. 
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501 Results are expressedin mean ± standard deviation (SD) unless mentioned. Results with 
502 p<0.05 are statistically significant.
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